Form 4: DocGo CCO Stephen Sugrue Reports RSU Grant, Tax Withholding
Insider Transaction Report
DocGo's Chief Compliance Officer, Stephen Sugrue, reported the acquisition of 321,055 restricted stock units and the disposition of 35,968 units for tax obligations.
Summary
- Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reported transactions involving the company's common stock.
- On December 12, 2025, Sugrue acquired 321,055 restricted stock units (RSUs) at a price of $0.
- These RSUs are granted under DocGo's 2021 Stock Incentive Plan and will vest in four equal annual installments starting from December 12, 2025.
- Following this acquisition, Sugrue beneficially owns 672,570 shares, which includes other RSUs with different vesting schedules.
- On December 15, 2025, Sugrue disposed of 35,968 RSUs at a price of $0.91 per share to satisfy tax liabilities.
- These disposed RSUs were part of grants made on December 12, 2023, and December 12, 2024.
- After the disposition, Sugrue's beneficial ownership stands at 636,602 shares.
Sentiment
Score: 6
Explanation: Slightly positive. The grant of RSUs is a positive for the executive and indicates continued alignment with the company. The tax withholding is a routine, neutral event.
Positives
- Stephen Sugrue, Chief Compliance Officer, received a significant grant of 321,055 restricted stock units (RSUs), aligning his interests with long-term shareholder value.
- The RSU grants are part of the company's 2021 Stock Incentive Plan, indicating ongoing executive compensation and retention strategies.
Negatives
- 35,968 restricted stock units were disposed of to cover tax liabilities, representing a reduction in direct beneficial ownership.
Future Outlook
The filing details future vesting schedules for restricted stock units, indicating a long-term incentive structure for the Chief Compliance Officer extending through December 2029 (four anniversaries of 12/12/2025).
Industry Context
This Form 4 filing reflects a routine insider transaction, common across publicly traded companies, where executives receive equity compensation in the form of restricted stock units and subsequently dispose of a portion to cover tax obligations upon vesting. It does not provide broader industry trends or competitive insights.
Stakeholder Impact
- Shareholders: Minor potential for dilution from the vesting of RSUs, but also indicates management's continued equity stake and alignment with long-term company performance.
- Employees: The RSU grant to a key executive may signal stability in executive compensation practices.
Next Steps
- Vesting of 321,055 RSUs in four equal annual installments on each of the first four anniversaries of December 12, 2025.
- Vesting of 80,549 RSUs in three equal annual installments on December 12, 2026, December 12, 2027, and December 12, 2028.
- Vesting of 87,209 RSUs in two equal annual installments on December 12, 2026, and December 12, 2027.
Key Dates
| Date | Description |
|---|---|
| 12/12/2023 | Grant date for some RSUs later disposed for tax liability. |
| 12/12/2024 | Grant date for some RSUs later disposed for tax liability. |
| 12/12/2025 | Date of RSU grant (321,055 units) and start of vesting schedule for these units. Also a vesting date for other RSUs. |
| 12/15/2025 | Date of disposition of RSUs for tax liability. |
| 12/12/2026 | Vesting date for previously granted RSUs. |
| 12/12/2027 | Vesting date for previously granted RSUs. |
| 12/12/2028 | Vesting date for previously granted RSUs. |
Keywords
DocGo, DCGO, Stephen Sugrue, Chief Compliance Officer, Form 4, SEC filing, insider transaction, restricted stock units, RSU, stock incentive plan, executive compensation, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.